249 related articles for article (PubMed ID: 18549935)
41. Pleural fluid viscosity may help identifying malignant pleural effusions.
Chang LC; Hua CC; Liu YC; Chu CM; Chen HJ; Lee N
Respirology; 2008 May; 13(3):341-5. PubMed ID: 18399854
[TBL] [Abstract][Full Text] [Related]
42. Quantitative detection of survivin in malignant pleural effusion for the diagnosis and prognosis of lung cancer.
Wu YK; Chen KT; Kuo YB; Huang YS; Chan EC
Cancer Lett; 2009 Jan; 273(2):331-5. PubMed ID: 18824294
[TBL] [Abstract][Full Text] [Related]
43. Bayesian analysis using continuous likelihood ratios for identifying pleural exudates.
Porcel JM; Peña JM; Vicente de Vera C; Esquerda A; Vives M; Light RW
Respir Med; 2006 Nov; 100(11):1960-5. PubMed ID: 16626953
[TBL] [Abstract][Full Text] [Related]
44. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
45. Prognostic factors in patients presenting with pleural effusion revealing malignancy.
Anevlavis S; Kouliatsis G; Sotiriou I; Koukourakis MI; Archontogeorgis K; Karpathiou G; Giatromanolaki A; Froudarakis ME
Respiration; 2014; 87(4):311-6. PubMed ID: 24457947
[TBL] [Abstract][Full Text] [Related]
46. Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis.
Sioris T; Sihvo E; Salo J; Räsänen J; Knuuttila A
Eur J Surg Oncol; 2009 May; 35(5):546-51. PubMed ID: 18644696
[TBL] [Abstract][Full Text] [Related]
47. Impact of cell arrangement of pleural effusion in survival of patients with breast cancer.
Camillo ND; Dos Santos GT; Prolla JC; Flôres ER; Introíni GO; Brackmann RL; da Cruz IB; Bica CG
Acta Cytol; 2014; 58(5):446-52. PubMed ID: 25377597
[TBL] [Abstract][Full Text] [Related]
48. A decision tree for differentiating tuberculous from malignant pleural effusions.
Porcel JM; Alemán C; Bielsa S; Sarrapio J; Fernández de Sevilla T; Esquerda A
Respir Med; 2008 Aug; 102(8):1159-64. PubMed ID: 18573650
[TBL] [Abstract][Full Text] [Related]
49. Osteopontin is involved in the formation of malignant pleural effusion in lung cancer.
Cui R; Takahashi F; Ohashi R; Yoshioka M; Gu T; Tajima K; Unnoura T; Iwakami S; Hirama M; Ishiwata T; Iwase A; Takahashi K
Lung Cancer; 2009 Mar; 63(3):368-74. PubMed ID: 18752867
[TBL] [Abstract][Full Text] [Related]
50. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.
Tian T; Li J; Hu W; Sun C; Zhou J
J Clin Lab Anal; 2019 Jul; 33(6):e22901. PubMed ID: 30985967
[TBL] [Abstract][Full Text] [Related]
51. Animal models of malignant pleural effusion.
Stathopoulos GT; Kalomenidis I
Curr Opin Pulm Med; 2009 Jul; 15(4):343-52. PubMed ID: 19387350
[TBL] [Abstract][Full Text] [Related]
52. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
53. Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion.
Verma A; Phua CK; Sim WY; Algoso RE; Tee KS; Lew SJ; Lim AY; Goh SK; Tai DY; Kor AC; Ho B; Abisheganaden J
Medicine (Baltimore); 2016 Jun; 95(26):e3996. PubMed ID: 27368006
[TBL] [Abstract][Full Text] [Related]
54. Pleural fluid findings as prognostic factors for malignant pleural mesothelioma.
Gonlugur TE; Gonlugur U
J Clin Lab Anal; 2008; 22(5):334-6. PubMed ID: 18803276
[TBL] [Abstract][Full Text] [Related]
55. Malignant pleural fluid from mesothelioma has potent biological activities.
Cheah HM; Lansley SM; Varano Della Vergiliana JF; Tan AL; Thomas R; Leong SL; Creaney J; Lee YC
Respirology; 2017 Jan; 22(1):192-199. PubMed ID: 27560254
[TBL] [Abstract][Full Text] [Related]
56. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.
Flores RM; Routledge T; Seshan VE; Dycoco J; Zakowski M; Hirth Y; Rusch VW
J Thorac Cardiovasc Surg; 2008 Sep; 136(3):605-10. PubMed ID: 18805259
[TBL] [Abstract][Full Text] [Related]
57. Malignant pleural effusion of multiple myeloma: prognostic factors and outcome.
Kamble R; Wilson CS; Fassas A; Desikan R; Siegel DS; Tricot G; Anderson P; Sawyer J; Anaissie E; Barlogie B
Leuk Lymphoma; 2005 Aug; 46(8):1137-42. PubMed ID: 16085553
[TBL] [Abstract][Full Text] [Related]
58. Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology.
Yu CJ; Wang CL; Wang CI; Chen CD; Dan YM; Wu CC; Wu YC; Lee IN; Tsai YH; Chang YS; Yu JS
J Proteome Res; 2011 Oct; 10(10):4671-82. PubMed ID: 21806062
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic and prognostic significance of receptor-binding cancer antigen expressed on SiSo cells in lung-cancer-associated pleural effusion.
Yang J; Zhu Y; Wu L; Zhu W; Zhang X; Yang Y; Xu C
Clin Respir J; 2018 Jan; 12(1):279-284. PubMed ID: 27402224
[TBL] [Abstract][Full Text] [Related]
60. [Survival of malignant and paramalignant pleural effusions in Ouagadougou].
Bambara AT; Ouédraogo SM; Maïga S; Sondo KA; Boncoungou/Nikièma K; Ouédraogo G; Koumbem B; Ouédraogo AS; Djibril M; Badoum G; Ouédraogo AR; Ouédraogo M
Rev Pneumol Clin; 2016 Dec; 72(6):346-352. PubMed ID: 27776946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
